Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

nintedanib MeSH Supplementary Concept Data 2025


MeSH Supplementary
nintedanib
Unique ID
C530716
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C530716
Entry Term(s)
BIBF 1120
BIBF-1120
BIBF1120
Nintedanib esylate
Ofev
Vargatef
Pharm Action
Antineoplastic Agents
Protein Kinase Inhibitors
Registry Numbers
G6HRD2P839
0
42F62RTZ4G
Related Numbers
42F62RTZ4G
CAS Type 1 Name
METHYL (3Z)-3-(((4-(N-METHYL-2-(4-METHYLPIPERAZIN-1-YL)ACETAMIDO)PHENYL)AMINO)(PHENYL)METHYLIDENE)-2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLATE
Heading Mapped to
*Indoles
Frequency
783
Source
Cancer Res 2008 Jun 15;68(12):4774-82
Date of Entry
2008/08/14
Revision Date
2019/09/07
nintedanib Preferred
BIBF 1120 Narrower
Vargatef Narrower
Nintedanib esylate Narrower
Ofev Narrower
page delivered in 0.006s